Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Nicholas Ltd Edition

Nicholas Ltd Edition Inc Class I (NCLEX)

Ticker NCLEX · · Holdings as of Jul 31, 2026

Expense ratio
0.86%$86/yr per $10k
5-yr return
+1.3%annualized
1-yr return
−10.4%as of Dec 2025
Net assets
$345.7Mall share classes
Holdings
62

Bottom line

Is NCLEX a good fund? The bottom line

NCLEX is the Class I share class of Nicholas Ltd Edition Inc, an actively managed large blend mutual fund from Nicholas Ltd Edition.

It charges 0.86% — about $86 a year on every $10,000 invested, more expensive than 53% of large blend funds we track.

It returned −10.4% over one year, +1.3% a year over five years, +8.3% a year over ten (as of Dec 31, 2025, per its prospectus).

With $346 million in net assets and 62 holdings, its largest position is Cohen & Steers Inc (3.0%) and the top 10 make up 24.1% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • 5-year return in the bottom quarter of its category

Updated Nov 19, 2026

What NCLEX invests in

The Fund strives to increase the value of your investment over the long-term (long-term growth).

To pursue the Funds investment objective of long-term growth, it primarily invests in common stocks of domestic corporations with small- and medium-sized market capitalizations believed to have growth potential. The Fund believes a companys annual sales volume and market capitalization (the number of shares outstanding multiplied by the per share price) are the factors most illustrative of a companys size. In distinguishing company size in terms of sales volume, the Fund considers a companys sales volume relative to peer companies in the companys industry. In terms of market capitalization, the Fund generally considers companies with market capitalizations within the range of the Russell 2000 Index as small, within the range of the Russell Midcap Index as medium, and within the range of the Standard & Poors 500 Index as large. To a lesser extent, the Fund may invest in companies with…

From the fund's prospectus (filed Jan 28, 2026).

NCLEX performance

Fund calendar-year total returns, 2016–2025 2016: +12.4%; 2017: +19.9%; 2018: −1.0%; 2019: +27.4%; 2020: +22.7%; 2021: +19.0%; 2022: −23.7%; 2023: +17.2%; 2024: +11.9%; 2025: −10.4% +12% 2016 +20% 2017 −1% 2018 +27% 2019 +23% 2020 +19% 2021 −24% 2022 +17% 2023 +12% 2024 −10% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
NCLEX−10.4%+1.3%+8.3%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full NCLEX performance history →

What NCLEX costs

On a $10,000 investment, NCLEX's 0.86% expense ratio costs about $86 a year. The prospectus estimates $1,061 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full NCLEX fee table →

NCLEX top 10 holdings

#Holding% of fund
1Cohen & Steers Inc CNS2.97%
2Dorman Products Inc DORM2.84%
3Encompass Health Corp EHC2.45%
4Q2 Holdings Inc QTWO2.38%
5Aptargroup Inc ATR2.31%
6Bio-techne Corp TECH2.30%
7La-z-boy Inc LZB2.24%
8Exlservice Holdings Inc EXLS2.22%
9Atricure Inc ATRC2.21%
10Eplus Inc PLUS2.21%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 24.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to NCLEX

More funds like NCLEX →

NCLEX FAQ

What is the expense ratio of NCLEX?
NCLEX's expense ratio is 0.86%, which works out to about $86 a year for every $10,000 invested. The prospectus estimates total costs of $1,061 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is NCLEX a good investment?
It depends on your goals, but the data points to: no front-end sales load; 5-year return in the bottom quarter of its category. This is general information, not personalized advice.
What does NCLEX hold?
NCLEX's largest holdings are Cohen & Steers Inc (3.0%), Dorman Products Inc (2.8%), Encompass Health Corp (2.5%), Q2 Holdings Inc (2.4%), Aptargroup Inc (2.3%). It holds 62 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is NCLEX's 5-year return?
NCLEX returned +1.3% a year over the five years ending Dec 31, 2025, and +8.3% a year over ten years. Past performance does not guarantee future results.
Does NCLEX have a sales load?
No. NCLEX has no front-end sales charge.
Who manages NCLEX?
NCLEX is offered by Nicholas Ltd Edition through NICHOLAS Ltd EDITION, INC..